Monday, March 1, 2021

Cipla gets USFDA nod for migraine drug

Cipla gets USFDA nod for migraine drug The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline#39;s Imitrex Nasal Spray.

from Moneycontrol Business News https://ift.tt/2OhK3rC

No comments:

Post a Comment

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...